Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Avricore Health (AVCRF) Stock Price & Analysis

AVCRF Stock Chart & Stats

$0.00-$0.00(-0.12%)
At close: 1:51 PM EDT
$0.03$0.04$0.054 May19 May1 Jun15 Jun29 Jun13 Jul27 Jul
Day’s Range
$0.03 - $0.03
52-Week Range
$0.02 - $0.08
Previous Close
$0.03
Volume
N/A
Average Volume (3M)
0
Market Cap
$4.52M
Enterprise Value
$5.89M
Total Cash (Recent Filing)
$922.55K
Total Debt (Recent Filing)
$0
Price to Earnings (P/E)
―
Beta
0.89
Next Earnings
Nov 26, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

Essentially no debt reduces refinancing exposure, interest expense, and the risk that creditors constrain strategic choices. This gives Avricore greater flexibility to direct available resources toward HealthTab adoption and operating improvements, although it does not offset current losses.

Prior Gross-profit Capability

Positive gross profit and improved margins in 2023–2024 show that the operating model has previously demonstrated underlying monetization potential. Re-establishing those economics would improve the durability of revenue growth and reduce dependence on external funding over time.

Integrated Pharmacy POCT Platform

HealthTab combines point-of-care testing, result management, and pharmacy workflow integration in one platform. A broader operating role within community pharmacies can support ongoing site usage and test-program expansion as participating locations and supported services increase.

Bears Say

Severe Revenue Deterioration

The sharp decline from stronger 2023–2024 revenue levels indicates substantial top-line volatility and weak recent commercial execution. Persistently low revenue can limit operating leverage, reduce investment capacity, and make it harder for the platform to absorb fixed costs as the business scales.

Negative Profitability

Negative gross profit means current revenue does not cover direct costs, while widening operating and net losses signal that scale has not yet produced sustainable earnings. Continued underperformance could weaken the equity base and constrain resources available for product and market expansion.

Cash Consumption

Negative operating and free cash flow show that the company is currently consuming cash rather than funding operations internally. If this persists, Avricore may have less flexibility to invest in HealthTab growth and face greater dependence on future financing to sustain operations.

Avricore Health News

AVCRF FAQ

What was Avricore Health’s price range in the past 12 months?
Avricore Health lowest stock price was $0.02 and its highest was $0.08 in the past 12 months.
What is Avricore Health’s market cap?
Avricore Health’s market cap is $4.52M.
When is Avricore Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Avricore Health’s earnings last quarter?
Avricore Health released its earnings results on Sep 01, 2026. The company reported -$0.002 earnings per share for the quarter.
Is Avricore Health overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Avricore Health pay dividends?
Avricore Health does not currently pay dividends.
What is Avricore Health’s EPS estimate?
Avricore Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avricore Health have?
Avricore Health has 126,369,670 shares outstanding.
What happened to Avricore Health’s price movement after its last earnings report?
Avricore Health reported an EPS of -$0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Avricore Health?
Currently, no hedge funds are holding shares in AVCRF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology